Hindland Equipment

We supply Mabtas 100 mg Injection, a high-quality biosimilar of Rituximab used in the treatment of certain cancers and autoimmune disorders. Manufactured by Intas Pharmaceuticals, Mabtas is commonly prescribed for non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis. It works by targeting CD20-positive B cells to reduce abnormal cell growth. The injection is administered under strict medical supervision in a hospital or clinical setting. We ensure genuine sourcing, proper cold-chain storage, and PAN India delivery. Available for bulk hospital supply or pharmacy distribution, Mabtas 100 mg offers an effective and affordable treatment solution with proven clinical results.

Brand - Intas

Brand - Zydus